Volume 271,
Number 12,
Issue of March 22, 1996 pp. 6933-6940
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
MAUB Is a New
Mucin Antigen Associated with Bladder Cancer
(Received for publication, December 6,
1995; and in revised form, January 9, 1996)
Alain
Bergeron ,
Serge
Champetier ,
Hélène
LaRue ,
Yves
Fradet
The M344 tumor-associated antigen, expressed in 70% of
superficial bladder tumors, is a sialylated carbohydrate present on a
high molecular mass thiol-reducible secreted mucin, which we named MAUB
for mucin antigen of the urinary bladder. Herein we studied the
relationship between MAUB and other known mucins in the MGH-U3 bladder
cancer line where MAUB expression is modulated by culture conditions.
Northern blots, immunoradiometric assays, and Western blots showed that
only MUC1 and MUC2 are expressed in this MAUB-positive cell line. MUC1
differs from MAUB by its molecular mass and its non-oligomeric nature,
while MUC2 has similar molecular mass and response to culture
conditions. However, in double determinant immunoradiometric assays,
MAUB and MUC2 did not cross-react. Moreover, confocal microscopy showed
different subcellular localization of the two antigens. Treatment of
MGH-U3 cells with MUC2 antisense oligodeoxynucleotides resulted in
decreased expression of MUC2 and increased expression of MAUB, ruling
out the possibility that monoclonal antibody M344 recognizes a
different glycosylated form of MUC2. In addition, we identified a tumor
specimen expressing MAUB but no MUC2 antigen or mRNA. Together, these
results suggest that there is expression of at least three mucins in
MGH-U3 cells and that MAUB is a cancer-associated mucin distinct from
those identified so far.